U.S. Medical Device Manufacturers Market Size, Share & Trends Analysis Report By Application (Orthopedic Devices, Cardiovascular Devices, Neurology Devices, Drug Delivery Devices, Ophthalmic Devices, Nephrology & Urology Devices), And Segment Forecasts, 2025 - 2030
Cholera Vaccines Market Growth & Trends
The global cholera vaccines market size is expected to reach USD 163.4 million by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 10.0% from 2025 to 2030. Increase in number of initiatives and rising awareness about cholera are major factors contributing toward market growth.
Governments in regions affected by cholera are striving to eliminate the disease by developing a strong public health and sanitation infrastructure. In February 2013, the Government of Haiti launched a 10-year National Cholera Elimination Plan. The United Nations Organization has made elimination of cholera a key UN priority and offers support to the Haitian Government by establishing a mechanism to respond to an alert within 48 hours, household visits, and sensitization campaigns.
Furthermore, various research projects and studies, such as epidemiological and anthropological studies, are being conducted in Africa. Ongoing studies include using rapid diagnostics tests to detect Vibrio cholerae in samples of water to understand epidemic diffusion mechanisms and anticipate outbreaks. The Cholera Platform is working with the Global Task Force for Cholera Control (GTFCC) WASH working group. This association aims to develop a method for conducting case studies to control and prevent the disease.
Cholera Vaccines Market Report Highlights
- The global cholera vaccine market size was valued at USD 93.9 million in 2024 and is anticipated to grow at a CAGR of 10.0% from 2025 to 2030
- By product, Dukoral vaccine dominated the market in 2024. The dominance can be attributed to the positive outcomes of this vaccine in preventing the disease since 2004. Dukoral is considered to be safe and stable
- The Vaxchora segment is expected to exhibit a lucrative CAGR over the forecast period owing to benefits associated with the vaccine, such as single dose immunization and reduced adverse effects
- North America held the largest share in 2024 due to factors such as increasing incidence and growing initiatives for raising awareness about the disease and vaccination
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Application
- 1.2.2. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in the U.S.
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.3. Competitive Insights
- Chapter 3. U.S. Medical Device Manufacturers Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing geriatric population
- 3.2.1.2. High adoption of minimally invasive procedures
- 3.2.1.3. Increase in the number of sports and road accidents
- 3.2.1.4. Increasing geographic reach of market players
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Increase in the number of product recalls
- 3.2.2.2. Social and ethical issues
- 3.2.2.3. Slow approval procedures
- 3.3. U.S. Medical Device Manufacturers Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic Landscape
- Chapter 4. U.S. Medical Device Manufacturers Market: Application Estimates & Trend Analysis
- 4.1. Application Market Share, 2024 & 2030
- 4.2. Segment Dashboard
- 4.3. U.S. Medical Device Manufacturers Market by Application Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Orthopedic Devices
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.2. Cardiovascular Devices
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.3. Neurology Devices
- 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.4. Drug Delivery Devices
- 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.5. Ophthalmic Devices
- 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.6. Nephrology and Urology Devices
- 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.7. Others
- 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- Chapter 5. Competitive Landscape
- 5.1. Recent Developments & Impact Analysis, By Key Market Participants
- 5.2. Company/Competition Categorization
- 5.3. Vendor Landscape
- 5.3.1. Key company market share analysis, 2024
- 5.3.2. Stryker
- 5.3.2.1. Company overview
- 5.3.2.2. Financial performance
- 5.3.2.3. Product benchmarking
- 5.3.2.4. Strategic initiatives
- 5.3.3. Cardinal Health
- 5.3.3.1. Company overview
- 5.3.3.2. Financial performance
- 5.3.3.3. Product benchmarking
- 5.3.3.4. Strategic initiatives
- 5.3.4. Eli Lily and Company
- 5.3.4.1. Company overview
- 5.3.4.2. Financial performance
- 5.3.4.3. Product benchmarking
- 5.3.4.4. Strategic initiatives
- 5.3.5. Intuitive Surgical
- 5.3.5.1. Company overview
- 5.3.5.2. Financial performance
- 5.3.5.3. Product benchmarking
- 5.3.5.4. Strategic initiatives
- 5.3.6. Edwards Lifesciences Corporation
- 5.3.6.1. Company overview
- 5.3.6.2. Financial performance
- 5.3.6.3. Product benchmarking
- 5.3.6.4. Strategic initiatives
- 5.3.7. BD
- 5.3.7.1. Company overview
- 5.3.7.2. Financial performance
- 5.3.7.3. Product benchmarking
- 5.3.7.4. Strategic initiatives
- 5.3.8. Danaher
- 5.3.8.1. Company overview
- 5.3.8.2. Financial performance
- 5.3.8.3. Product benchmarking
- 5.3.8.4. Strategic initiatives
- 5.3.9. 3M
- 5.3.9.1. Company overview
- 5.3.9.2. Financial performance
- 5.3.9.3. Product benchmarking
- 5.3.9.4. Strategic initiatives
- 5.3.10. Abbott
- 5.3.10.1. Company overview
- 5.3.10.2. Financial performance
- 5.3.10.3. Product benchmarking
- 5.3.10.4. Strategic initiatives
- 5.3.11. Baxter
- 5.3.11.1. Company overview
- 5.3.11.2. Financial performance
- 5.3.11.3. Product benchmarking
- 5.3.11.4. Strategic initiatives
- 5.3.12. B. Braun SE
- 5.3.12.1. Company overview
- 5.3.12.2. Financial performance
- 5.3.12.3. Product benchmarking
- 5.3.12.4. Strategic initiatives
- 5.3.13. GE HealthCare
- 5.3.13.1. CompanOverviewew
- 5.3.13.2. Financial performance
- 5.3.13.3. Product benchmarking
- 5.3.13.4. Strategic initiatives
- 5.3.14. Johnson & Johnson Services, Inc.
- 5.3.14.1. CompanOverviewew
- 5.3.14.2. Financial performance
- 5.3.14.3. Product benchmarking
- 5.3.14.4. Strategic initiatives
- 5.3.15. Medtronic
- 5.3.15.1. Company overview
- 5.3.15.2. Financial performance
- 5.3.15.3. Product benchmarking
- 5.3.15.4. Strategic initiatives
- 5.3.16. Boston Scientific Corporation
- 5.3.16.1. CompanOverviewew
- 5.3.16.2. Financial performance
- 5.3.16.3. Product benchmarking
- 5.3.16.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook